Torii Pharmaceutical Co., Ltd. (TYO:4551)
Japan flag Japan · Delayed Price · Currency is JPY
4,395.00
-55.00 (-1.24%)
Mar 10, 2025, 3:30 PM JST

Torii Pharmaceutical Revenue

In the year 2024, Torii Pharmaceutical had annual revenue of 60.43B JPY with 10.59% growth. Torii Pharmaceutical had revenue of 17.09B in the quarter ending December 31, 2024, with 10.23% growth.

Revenue
60.43B
Revenue Growth
+10.59%
P/S Ratio
2.09
Revenue / Employee
103.65M
Employees
583
Market Cap
126.19B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202460.43B5.79B10.59%
Dec 31, 202354.64B5.74B11.74%
Dec 31, 202248.90B1.91B4.06%
Dec 31, 202146.99B5.29B12.68%
Dec 31, 202041.70B-1.30B-3.02%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Chugai Pharmaceutical 1,170.61B
Takeda Pharmaceutical Company 4,579.02B
Daiichi Sankyo Company 1,795.99B
HOYA Corporation 837.44B
Terumo 1,011.15B
Otsuka Holdings 2,329.86B
Astellas Pharma 1,867.63B
Olympus 993.33B
Revenue Rankings